| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Income before income taxes | 44,595 | 40,211 | 27,779 | 38,806 |
| Income tax expense (benefit) | -27,184 | 13,545 | 8,792 | 6,041 |
| Net loss | 71,779 | 26,666 | 18,987 | 32,765 |
| Diluted | 0.42 | 0.16 | 0.11 | 0.2 |
| Earnings per share, basic, total | 0.43 | 0.16 | 0.11 | 0.2 |
| Weighted average common shares outstanding, basic | 168,836,000 | 167,827,000 | 166,808,000 | 165,974,000 |
| Weighted average common shares outstanding, diluted | 170,650,000 | 168,681,000 | 167,668,000 | 166,178,000 |
ACADIA PHARMACEUTICALS INC (ACAD)
ACADIA PHARMACEUTICALS INC (ACAD)